Asset Details
Do you wish to reserve the book?
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients
Do you wish to request the book?
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients
2024
Overview
Thromboembolic (TE) complications [myocardial infarction (MI), stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE)] are common causes of mortality in hospitalised COVID-19 patients. Therefore, this review was undertaken to explore the incidence of TE complications and mortality associated with TE complications in hospitalised COVID-19 patients from different studies. A literature search was performed using ScienceDirect and PubMed databases using the MeSH term search strategy of “COVID-19”, “thromboembolic complication”, “venous thromboembolism”, “arterial thromboembolism”, “deep vein thrombosis”, “pulmonary embolism”, “myocardial infarction”, “stroke”, and “mortality”. There were 33 studies included in this review. Studies have revealed that COVID-19 patients tend to develop venous thromboembolism (PE:1.0-40.0% and DVT:0.4-84%) compared to arterial thromboembolism (stroke:0.5-15.2% and MI:0.8-8.7%). Lastly, the all-cause mortality of COVID-19 patients ranged from 4.8 to 63%, whereas the incidence of mortality associated with TE complications was between 5% and 48%. A wide range of incidences of TE complications and mortality associated with TE complications can be seen among hospitalized COVID-19 patients. Therefore, every patient should be assessed for the risk of thromboembolic complications and provided with an appropriate thromboprophylaxis management plan tailored to their individual needs.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Complications and side effects
/ COVID-19
/ Embolism
/ Hospitalization - statistics & numerical data
/ Humans
/ Medicine
/ Myocardial Infarction - complications
/ Myocardial Infarction - epidemiology
/ Myocardial Infarction - mortality
/ Pulmonary Embolism - epidemiology
/ Pulmonary Embolism - etiology
/ Pulmonary Embolism - mortality
/ Severe acute respiratory syndrome coronavirus 2
/ Stroke
/ Systematic Reviews on Infectious Diseases
/ Thromboembolism - epidemiology
/ Veins
/ Venous Thromboembolism - epidemiology
/ Venous Thromboembolism - etiology
/ Venous Thromboembolism - prevention & control
